Skip to main content

Recent Cannabis Use Tied to Higher Risk of Current Asthma

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 4, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Feb. 2, 2024 -- There is a dose-response relationship between frequency of current cannabis use and the prevalence of current asthma, according to a study published in the February issue of Preventive Medicine.

Renee D. Goodwin, Ph.D., from City University of New York in New York City, and colleagues used data from the 2020 National Survey on Drug Use and Health (32,893 participants ≥12 years) to estimate the prevalence of asthma by frequency of past 30-day cannabis use.

The researchers found that current asthma was significantly more common among U.S. individuals who reported cannabis use in the past 30 days versus those who did not (9.8 versus 7.4 percent). Among individuals reporting cannabis use 20 to 30 days/month, the odds of asthma were significantly greater (adjusted odds ratio, 1.67). Similar results were seen for blunt use six to 15 and 20 to 30 days/month (adjusted odds ratios, 1.9 and 2.2, respectively) compared to no use. There was a positive linear relationship observed between frequency of cannabis use and blunt use and current asthma prevalence.

“Our findings add a significant layer to the nascent body of research on potential harms associated with cannabis use by being the first to show a link between cannabis use in the community and respiratory health risks, specifically increased asthma prevalence," Goodwin said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler Regimen

THURSDAY, May 23, 2024 -- Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) inhaler...

Researchers Compare Race-Based, Race-Neutral Lung Function Equations

TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...

Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD

TUESDAY, May 21, 2024 -- For adults with undiagnosed asthma and chronic obstructive pulmonary disease (COPD), receipt of pulmonologist-directed treatment is associated with less...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.